FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3096551639> ?p ?o ?g. }

• W3096551639 endingPage "889" @default.
• W3096551639 startingPage "881" @default.
• W3096551639 abstract "Purpose Hyaluronic acid (HA) fillers can be reversed with hyaluronidase, but their dose responses are not well-characterized. We evaluated 12 fillers’ in vitro responses to varying doses of recombinant human hyaluronidase (RHH). Methods For the 12 HA gels, 0.2 mL aliquots were placed on six slides. Samples received no injection, saline injection, or RHH (2.5, 5, 10, or 20 units). The most resistant gels received 40 units of RHH on a seventh slide. Photos of gels were taken from bird's-eye and lateral views with a ruler at multiple time points. Results Restylane-L and Restylane Lyft were the most easily dissolvable HA fillers. Both demonstrated a significant response to 2.5 units RHH/0.2 mL. Juvéderm Ultra, Belotero, Restylane Silk, and Restylane Defyne had moderate resistance to RHH. Restylane Refyne, Juvéderm Ultra Plus, Vollure, Versa, and Voluma were most resistant, requiring more than 20 units RHH/0.2 mL for complete dissolution. Volbella was moderately resistant up to 20 units RHH but demonstrated pronounced dissolution with 40 units RHH. Conclusions This study visually and objectively demonstrates the in vitro response of HA to dissolution by hyaluronidase. Fillers were categorized into least, moderate, and most resistant to RHH. Interesting findings include markedly different degrees of liquefaction for products used for similar indications (such as Restylane Lyft being more liquefied than Voluma), and Belotero easily flattening but retaining texture. Combined with in vivo data, this may help calculate hyaluronidase doses needed for controlled, partial reversal of commercially available HA gels. Hyaluronic acid (HA) fillers can be reversed with hyaluronidase, but their dose responses are not well-characterized. We evaluated 12 fillers’ in vitro responses to varying doses of recombinant human hyaluronidase (RHH). For the 12 HA gels, 0.2 mL aliquots were placed on six slides. Samples received no injection, saline injection, or RHH (2.5, 5, 10, or 20 units). The most resistant gels received 40 units of RHH on a seventh slide. Photos of gels were taken from bird's-eye and lateral views with a ruler at multiple time points. Restylane-L and Restylane Lyft were the most easily dissolvable HA fillers. Both demonstrated a significant response to 2.5 units RHH/0.2 mL. Juvéderm Ultra, Belotero, Restylane Silk, and Restylane Defyne had moderate resistance to RHH. Restylane Refyne, Juvéderm Ultra Plus, Vollure, Versa, and Voluma were most resistant, requiring more than 20 units RHH/0.2 mL for complete dissolution. Volbella was moderately resistant up to 20 units RHH but demonstrated pronounced dissolution with 40 units RHH. This study visually and objectively demonstrates the in vitro response of HA to dissolution by hyaluronidase. Fillers were categorized into least, moderate, and most resistant to RHH. Interesting findings include markedly different degrees of liquefaction for products used for similar indications (such as Restylane Lyft being more liquefied than Voluma), and Belotero easily flattening but retaining texture. Combined with in vivo data, this may help calculate hyaluronidase doses needed for controlled, partial reversal of commercially available HA gels." @default.
• W3096551639 created "2020-11-09" @default.
• W3096551639 creator A5070835986 @default.
• W3096551639 creator A5076099967 @default.
• W3096551639 creator A5089017265 @default.
• W3096551639 date "2021-04-01" @default.
• W3096551639 modified "2023-10-02" @default.
• W3096551639 title "Response of twelve different hyaluronic acid gels to varying doses of recombinant human hyaluronidase" @default.
• W3096551639 cites W1988318745 @default.
• W3096551639 cites W1992587948 @default.
• W3096551639 cites W2001019626 @default.
• W3096551639 cites W2019945361 @default.
• W3096551639 cites W2048668157 @default.
• W3096551639 cites W2071573102 @default.
• W3096551639 cites W2091296917 @default.
• W3096551639 cites W2101842736 @default.
• W3096551639 cites W2103258952 @default.
• W3096551639 cites W2415818694 @default.
• W3096551639 cites W2802256628 @default.
• W3096551639 cites W2808528625 @default.
• W3096551639 cites W2895377446 @default.
• W3096551639 cites W2928079033 @default.
• W3096551639 cites W3095133870 @default.
• W3096551639 doi "https://doi.org/10.1016/j.bjps.2020.10.051" @default.
• W3096551639 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33308988" @default.
• W3096551639 hasPublicationYear "2021" @default.
• W3096551639 type Work @default.
• W3096551639 sameAs 3096551639 @default.
• W3096551639 citedByCount "10" @default.
• W3096551639 countsByYear W30965516392021 @default.
• W3096551639 countsByYear W30965516392022 @default.
• W3096551639 countsByYear W30965516392023 @default.
• W3096551639 crossrefType "journal-article" @default.
• W3096551639 hasAuthorship W3096551639A5070835986 @default.
• W3096551639 hasAuthorship W3096551639A5076099967 @default.
• W3096551639 hasAuthorship W3096551639A5089017265 @default.
• W3096551639 hasConcept C105702510 @default.
• W3096551639 hasConcept C126322002 @default.
• W3096551639 hasConcept C141071460 @default.
• W3096551639 hasConcept C150903083 @default.
• W3096551639 hasConcept C181199279 @default.
• W3096551639 hasConcept C207001950 @default.
• W3096551639 hasConcept C2777397205 @default.
• W3096551639 hasConcept C2777529286 @default.
• W3096551639 hasConcept C2778445172 @default.
• W3096551639 hasConcept C2780375986 @default.
• W3096551639 hasConcept C55493867 @default.
• W3096551639 hasConcept C71924100 @default.
• W3096551639 hasConcept C86803240 @default.
• W3096551639 hasConceptScore W3096551639C105702510 @default.
• W3096551639 hasConceptScore W3096551639C126322002 @default.
• W3096551639 hasConceptScore W3096551639C141071460 @default.
• W3096551639 hasConceptScore W3096551639C150903083 @default.
• W3096551639 hasConceptScore W3096551639C181199279 @default.
• W3096551639 hasConceptScore W3096551639C207001950 @default.
• W3096551639 hasConceptScore W3096551639C2777397205 @default.
• W3096551639 hasConceptScore W3096551639C2777529286 @default.
• W3096551639 hasConceptScore W3096551639C2778445172 @default.
• W3096551639 hasConceptScore W3096551639C2780375986 @default.
• W3096551639 hasConceptScore W3096551639C55493867 @default.
• W3096551639 hasConceptScore W3096551639C71924100 @default.
• W3096551639 hasConceptScore W3096551639C86803240 @default.
• W3096551639 hasFunder F4320306811 @default.
• W3096551639 hasIssue "4" @default.
• W3096551639 hasLocation W30965516391 @default.
• W3096551639 hasOpenAccess W3096551639 @default.
• W3096551639 hasPrimaryLocation W30965516391 @default.
• W3096551639 hasRelatedWork W1911758895 @default.
• W3096551639 hasRelatedWork W2103258952 @default.
• W3096551639 hasRelatedWork W2128237198 @default.
• W3096551639 hasRelatedWork W2267349551 @default.
• W3096551639 hasRelatedWork W2357254812 @default.
• W3096551639 hasRelatedWork W2369424775 @default.
• W3096551639 hasRelatedWork W2403000122 @default.
• W3096551639 hasRelatedWork W2415978481 @default.
• W3096551639 hasRelatedWork W3017909151 @default.
• W3096551639 hasRelatedWork W4205493591 @default.
• W3096551639 hasVolume "74" @default.
• W3096551639 isParatext "false" @default.
• W3096551639 isRetracted "false" @default.
• W3096551639 magId "3096551639" @default.
• W3096551639 workType "article" @default.